Physician profile
Michael Sumner
NPI 1639528656
$3,818.10
in general payments reported to CMS, 2019-2025
18 companies · $2,088 in 2025
The $2,088 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.19 · 2021: $19.20 · 2022: $366 · 2023: $118 · 2024: $1,215 · 2025: $2,088.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,160 · Travel and Lodging: $1,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,159.77 |
| Travel and Lodging | $1,262.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,021.65 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip, Cardiomems |
| Abiomed | $532.91 | 2022-2024 | Impella |
| Novartis Pharmaceuticals Corporation | $222.98 | 2024-2025 | |
| Edwards Lifesciences Corporation | $178.71 | 2021-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astrazeneca Pharmaceuticals LP | $177.48 | 2024-2025 | Andexxa, Farxiga, Wainua |
| E.R. Squibb & Sons, L.L.C. | $142.23 | 2024-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $101.85 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Cvrx, INC. | $91.42 | 2024 | Barostim Neo System |
| Philips North America LLC | $75.01 | 2023-2025 | (Ck4) Mcot, Mcot |
| Amgen INC. | $58.04 | 2020-2025 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.33 | 2024-2025 | Lifevest |
| Angiodynamics, INC. | $38.88 | 2025 | Alphavac |
| Lexicon Pharmaceuticals, INC. | $33.82 | 2023-2024 | Inpefa |
| Pfizer INC. | $21.50 | 2023 | |
| Boston Scientific Corporation | $20.48 | 2025 | Watchman Flx |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $20.06 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $19.65 | 2025 | |
| Lilly USA, LLC | $16.10 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sumner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.